APFIEQ-CyL |
Promotion of Training and Research in Surgical Specialties in Castilla and León |
BCG |
Bacillus Calmette-Guerin |
BFB |
Biofeedback (BFB) |
BFB+ |
Group receiving adjuvant biofeedback |
BFB− |
Group of patients who did not receiving biofeedback of pelvic floor. |
BMI |
Body mass index |
BPS |
Bladder pain syndrome |
BTX-A |
Botulinum toxin type A |
CI |
Confidence interval |
CPP |
Chronic pelvic pain |
DM |
Diabetes mellitus |
DMSO |
Dimethyl sulfoxide |
EAU |
The European Association of Urology |
EMDA |
Electromotive drug administration |
EMG-BFB |
Electromyographic biofeedback |
ESSIC |
The International Society for the Study of BPS (formerly, European Society for the Study of Interstitial Cystitis) |
GAG |
Intravesical glycosaminoglycans |
HBO |
Hyperbaric oxygen |
HT |
Hypertension |
HRQOL |
Health-related quality of life |
IASP |
The International Association for the Study of Pain |
IC |
Interstitial cistitis |
IPD-1151T |
Suplatast tosilate |
LD |
Length of disease |
RTX |
Resiniferatoxin |
SD |
Standard deviation |
TUR |
Transurethral resection |
UI |
Urinary incontinence |
UTI |
Urinary tract infection |